Development of a novel influenza A antiviral assay

Journal of Virological Methods

Volumn 105, Issue 1, 2002, Pages 105-114

  Wagaman, Pamela C ^a   Leong, Margaret A ^a   Simmen, Kenneth A ^a  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Antiviral assay; Branched DNA; Influenza virus replication

Indexed keywords

ANTIVIRUS AGENT; NUCLEOPROTEIN; OLIGONUCLEOTIDE; RIMANTADINE; VIRUS DNA; VIRUS RNA; ZANAMIVIR; CORE PROTEIN; GUANIDINE DERIVATIVE; NP PROTEIN; NUCLEOCAPSID PROTEIN; PYRAN DERIVATIVE; SIALIC ACID DERIVATIVE;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; ASSAY; CELL STRAIN; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DNA DETERMINATION; GENE TECHNOLOGY; INFLUENZA; INFLUENZA VIRUS A; NONHUMAN; PRIORITY JOURNAL; REPRODUCIBILITY; RNA ANALYSIS; VALIDATION PROCESS; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TYPING; ANIMAL; BRANCHED DNA SIGNAL AMPLIFICATION ASSAY; CELL LINE; DOG; DRUG EFFECT; EVALUATION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; OLIGONUCLEOTIDE PROBE; VIROLOGY;

ANIMAL; ANTIVIRAL AGENTS; BRANCHED DNA SIGNAL AMPLIFICATION ASSAY; CELL LINE; DOGS; HUMAN; INFLUENZA; INFLUENZA A VIRUS, HUMAN; MICROBIAL SENSITIVITY TESTS; NUCLEOPROTEINS; OLIGONUCLEOTIDE PROBES; RIMANTADINE; RNA, VIRAL; SIALIC ACIDS; VIRAL CORE PROTEINS; VIRUS REPLICATION; ANIMALS; GUANIDINES; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; NUCLEOCAPSID PROTEINS; PYRANS; ZANAMIVIR;

INFLUENZA VIRUS;

EID: 0035993308     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(02)00088-5     Document Type: Article

References (25)

1. ProbeDesigner: For the design of probesets for branched DNA (bDNA) signal amplification assays
2. Update: Influenza activity - United States, 1995-96 season
3. Influenza
4. Quantitative detection of hepatitis C virus RNA with a solid phase signal amplification method: Definition of optimal conditions for specimen collection and clinical application in interferon-treated patients
5. Accurate quantification of hepatitis C virus (HCV) RNA from all HCV genotypes by using branched-DNA technology
6. Evolution of the nucleoprotein gene of influenza A virus
7. Evolution of influenza A virus nucleoprotein genes: Implications for the origins of H1N1 human and classical swine viruses
8. Influenza virus neuraminidase inhibitors
9. Plaque inhibition assay for drug susceptibility testing of influenza viruses
10. Quantitation of HBV DNA in human serum using a branched DNA (bDNA) signal amplification assay
11. Orthomyxoviridae: The viruses and their replication
12. Virological methods for the generation and characterization of influenza viruses with reduced sensitivity to 4-guanidino-Neu5Ac2en
13. Optimization of in situ cellular ELISA performed on influenza A virus-infected monolayers for screening of antiviral agents
14. Targeting influenza virus neuraminidase - A new strategy for antiviral therapy
15. Rapid and precise quantification of HIV-1 RNA in plasma using a branched DNA signal amplification assay
16. Comparison of RNA hybridization, hemagglutination assay, titration of infectious virus and immunofluorescence as methods for monitoring influenza virus replication in vitro
17. In vitro and in vivo assay systems for study of influenza virus inhibitors
18. Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities
19. Emerging technologies for accelerated toxicity evaluation of potential drug candidates
20. A novel method for the detection of hepatitis B virus in human serum samples without blotting or radioactivity
21. Branched DNA amplification multimers for the sensitive, direct detection of human hepatitis viruses
22. Zanamivir
23. Neuraminidase inhibitors for treatment of influenza A and B infections
24. A branched DNA signal amplification assay to quantitate messenger RNA of human uncoupling proteins 1, 2, and 3